The inhibitor inhibited the peptidase activity of recombinant DNPEP by 95.0% ± 1.4% [18] and by 88% in Mec-1 CLL cell lysate (at 12.5 μM and 25 μM, respectively, Figure S2). This evidence concerns the gene LAP3 and B-cell chronic lymphocytic leukemia.